IMTX
Price
$10.34
Change
+$0.45 (+4.55%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.25B
111 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$11.96
Change
+$0.83 (+7.46%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
995.48M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs KURA

Header iconIMTX vs KURA Comparison
Open Charts IMTX vs KURABanner chart's image
Immatics
Price$10.34
Change+$0.45 (+4.55%)
Volume$15.71K
Capitalization1.25B
Kura Oncology
Price$11.96
Change+$0.83 (+7.46%)
Volume$29.18K
Capitalization995.48M
IMTX vs KURA Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. KURA commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (IMTX: $9.88 vs. KURA: $11.15)
Brand notoriety: IMTX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 21% vs. KURA: 34%
Market capitalization -- IMTX: $1.25B vs. KURA: $995.48M
IMTX [@Biotechnology] is valued at $1.25B. KURA’s [@Biotechnology] market capitalization is $995.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, KURA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 3 bearish.
  • KURA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both IMTX and KURA are a good buy in the short-term.

Price Growth

IMTX (@Biotechnology) experienced а -9.94% price change this week, while KURA (@Biotechnology) price change was -3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.25B) has a higher market cap than KURA($995M). IMTX YTD gains are higher at: 38.959 vs. KURA (28.014). IMTX has higher annual earnings (EBITDA): -58.05M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. IMTX (478M). IMTX has less debt than KURA: IMTX (17.1M) vs KURA (19.5M). IMTX has higher revenues than KURA: IMTX (130M) vs KURA (83.3M).
IMTXKURAIMTX / KURA
Capitalization1.25B995M125%
EBITDA-58.05M-192.46M30%
Gain YTD38.95928.014139%
P/E Ratio27.61N/A-
Revenue130M83.3M156%
Total Cash478M631M76%
Total Debt17.1M19.5M88%
FUNDAMENTALS RATINGS
IMTX vs KURA: Fundamental Ratings
IMTX
KURA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
3637
P/E GROWTH RATING
1..100
53100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for IMTX (74) in the null industry. This means that KURA’s stock grew somewhat faster than IMTX’s over the last 12 months.

IMTX's Profit vs Risk Rating (94) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IMTX’s stock grew similarly to KURA’s over the last 12 months.

IMTX's SMR Rating (94) in the null industry is in the same range as KURA (97) in the Biotechnology industry. This means that IMTX’s stock grew similarly to KURA’s over the last 12 months.

IMTX's Price Growth Rating (36) in the null industry is in the same range as KURA (37) in the Biotechnology industry. This means that IMTX’s stock grew similarly to KURA’s over the last 12 months.

IMTX's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for KURA (100) in the Biotechnology industry. This means that IMTX’s stock grew somewhat faster than KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXKURA
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
85%
Momentum
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
70%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 6 days ago
72%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 24 days ago
79%
N/A
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
75%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
81%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OISGX15.50N/A
N/A
Optimum Small-Mid Cap Growth Instl
JHARX10.52N/A
N/A
JHancock Multi-Asset Absolute Return R2
SCIJX21.80N/A
N/A
Hartford Schroders International Stk SDR
GCEEX11.10N/A
N/A
Goldman Sachs Clean Energy Income R6
MAIFX10.79N/A
N/A
MoA International Fund

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.70%
IDYA - IMTX
55%
Loosely correlated
-1.75%
VYGR - IMTX
51%
Loosely correlated
-4.89%
SYRE - IMTX
51%
Loosely correlated
-0.91%
CGON - IMTX
51%
Loosely correlated
-4.35%
KURA - IMTX
50%
Loosely correlated
-2.53%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.53%
XNCR - KURA
58%
Loosely correlated
-3.15%
CLDX - KURA
53%
Loosely correlated
+2.85%
RGNX - KURA
53%
Loosely correlated
-3.10%
IMTX - KURA
51%
Loosely correlated
-3.70%
DYN - KURA
48%
Loosely correlated
-2.96%
More